There was no difference in markers of mineral metabolism (intact parathyroid hormone, serum calcium, and phosphorus), dyslipidemia (total cholesterol, triglycerides, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol), inflammation (homocysteine, fibrinogen, and high-sensitivity C-reactive protein), nutrition (total protein and serum albumin) and therapy (antiplatelet agents and statins). The gene discussed is PTH; the disease is metabolic syndrome.